Lupin Coughs Up $150 Million Cash for This New Jersey-Based Biopharma

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-deal3.jpg" NAME"Lupin Coughs Up $150 Million Cash for This New Jersey-Based Biopharma" ALT"Lupin Coughs Up $150 Million Cash for This New Jersey-Based Biopharma"October 11, 2017By Alex Keown, BioSpace.com Breaking…

Continue ReadingLupin Coughs Up $150 Million Cash for This New Jersey-Based Biopharma

Janssen R&D Establishes First-Of-Its-Kind Mobile Medication And Data Management Technology Platform For Industry Use

  • Post author:
  • Post category:BioPharma

RARITAN, N.J., Oct. 11, 2017 /PRNewswire/ --Janssen Research & Development, LLC (Janssen) today announced that it has established the Integrated Smart Trial & Engagement Platform (iSTEP), a first-of-its-kind information technology…

Continue ReadingJanssen R&D Establishes First-Of-Its-Kind Mobile Medication And Data Management Technology Platform For Industry Use

Why AstraZeneca PLC CEO Took a Job His Friends Called a Suicide Mission

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-astrazeneca-pascal-soriot.jpg" NAME"Why AstraZeneca PLC CEO Took a Job His Friends Called a Suicide Mission" ALT"Why AstraZeneca PLC CEO Took a Job His Friends Called a Suicide Mission"October 11, 2017By…

Continue ReadingWhy AstraZeneca PLC CEO Took a Job His Friends Called a Suicide Mission

Avita Medical Taps Investors for A$16.9 Million to Commercialise Its 'Spray-On Skin'

  • Post author:
  • Post category:BioPharma

Avita Medical A$16.9 Million Capital RaisingVALENCIA, Calif. & PERTH, Australia & LONDON--(BUSINESS WIRE)--Avita Medical (ASX: <a target"_blank" href"http://cts.businesswire.com/ct/CT?idsmartlink&urlhttp%3A%2F%2Fwww.asx.com.au%2Fasx%2Fshare-price-research%2Fcompany%2FAVH&esheet516... Source: BioSpace

Continue ReadingAvita Medical Taps Investors for A$16.9 Million to Commercialise Its 'Spray-On Skin'

Flexion Eyes Creation of 100 New Sales Jobs to Sell Just-Approved Osteoarthritis Drug

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-flexion-mike-clayman.jpg" NAME"Flexion Eyes Creation of 100 New Sales Jobs to Sell Just-Approved Osteoarthritis Drug" ALT"Flexion Eyes Creation of 100 New Sales Jobs to Sell Just-Approved Osteoarthritis Drug"October 11, 2017By…

Continue ReadingFlexion Eyes Creation of 100 New Sales Jobs to Sell Just-Approved Osteoarthritis Drug

<b>Janpix</b> Launches With $22 Million and Will be Helmed by Ex-Boehringer Ingelheim Exec

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-janpix-patrick-gunning.jpg" NAME"Janpix Launches With $22 Million and Will be Helmed by Former Boehringer Ingelheim Exec" ALT"Janpix Launches With $22 Million and Will be Helmed by Former Boehringer Ingelheim Exec"October…

Continue Reading<b>Janpix</b> Launches With $22 Million and Will be Helmed by Ex-Boehringer Ingelheim Exec

Rhythm Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters??? Option To Purchase Additional Shares

  • Post author:
  • Post category:BioPharma

BOSTON, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for treatment of rare genetic deficiencies that…

Continue ReadingRhythm Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters??? Option To Purchase Additional Shares

Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks" ALT"Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks"October 11, 2017By Mark Terry, BioSpace.com Breaking…

Continue ReadingWall Street's Top Biotech Analyst Loves These 2 Life Science Stocks

<b>Mike Hooven</b>, Founder Of AtriCure And Enable Injections, Joins Genetesis Board Of Directors

  • Post author:
  • Post category:BioPharma

Veteran Medical Device Entrepreneur Adds Experience, Connections to Cardiac Imaging Startup MASON, Ohio--(BUSINESS WIRE)--Genetesis, a medical technology company that gives doctors an accurate, non-invasive tool for seeing how the heart…

Continue Reading<b>Mike Hooven</b>, Founder Of AtriCure And Enable Injections, Joins Genetesis Board Of Directors